ANNUAL REPORT

Company

AYTU BIOPHARMA, INC

Filed

November 26, 2013

Period of Report

August 31, 2013

Accession Number

0001079974-13-000764

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →